However, by day 35, mRNA expressions of Notch receptor NOTCH1, NOTCH receptor ligands DLL1 and JAG1 as well as the downstream targets HEY1 and HES5 were significantly higher in day 35 MELAS compared to controls (Fig. 3b). The gene discussed is DLL1; the disease is MELAS.